(VIANEWS) – Neurocrine Biosciences (NBIX), Genmab (GMAB), Progressive Corporation (PGR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Neurocrine Biosciences (NBIX)
21.9% sales growth and 12.68% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $2.47.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 55.03. Meaning, the purchaser of the share is investing $55.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.68%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 225.3% and 24.2%, respectively.
2. Genmab (GMAB)
17.9% sales growth and 14.78% return on equity
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
Earnings Per Share
As for profitability, Genmab has a trailing twelve months EPS of $0.96.
PE Ratio
Genmab has a trailing twelve months price to earnings ratio of 30.48. Meaning, the purchaser of the share is investing $30.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.78%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.9%, now sitting on 16.47B for the twelve trailing months.
3. Progressive Corporation (PGR)
14.9% sales growth and 21.58% return on equity
The Progressive Corporation, an insurance holding company, provides personal and commercial auto, personal residential and commercial property, business related general liability, and other specialty property-casualty insurance products and related services in the United States. It operates in three segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment writes insurance for personal autos and recreational vehicles (RV). This segment's products include personal auto insurance; and special lines products, including insurance for motorcycles, ATVs, RVs, watercrafts, snowmobiles, and related products. The Commercial Lines segment provides auto-related liability and physical damage insurance, and business-related general liability and property insurance for autos, vans, and pick-up trucks used by small businesses, as well as non-fleet taxis, black-car services, and airport taxis; tractors, trailers, and straight trucks primarily used by regional general freight and expeditor-type businesses, and long-haul operators; dump trucks used by light contractors and heavy constructions; log trucks and garbage trucks used by dirt, sand and gravel, logging, garbage/debris removal, and coal-type businesses; and tow trucks and wreckers used in towing services and gas/service station businesses. The Property segment writes residential property insurance for homeowners, other property owners, and renters, as well as offers manufactured homes, personal umbrella insurance, and primary and excess flood insurance. The company offers policy issuance and claims adjusting services; acts as an agent to homeowners, general liability, workers' compensation insurance, and other products; and reinsurance services. It sells its products through independent insurance agencies, as well as through mobile applications and over the phone. The Progressive Corporation was founded in 1937 and is headquartered in Mayfield Village, Ohio.
Earnings Per Share
As for profitability, Progressive Corporation has a trailing twelve months EPS of $6.57.
PE Ratio
Progressive Corporation has a trailing twelve months price to earnings ratio of 31.04. Meaning, the purchaser of the share is investing $31.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.58%.
Moving Average
Progressive Corporation’s worth is way above its 50-day moving average of $178.78 and way higher than its 200-day moving average of $150.67.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 3, 2024, the estimated forward annual dividend rate is 1.15 and the estimated forward annual dividend yield is 0.58%.
Sales Growth
Progressive Corporation’s sales growth is 13.8% for the present quarter and 14.9% for the next.
Yearly Top and Bottom Value
Progressive Corporation’s stock is valued at $203.90 at 06:22 EST, higher than its 52-week high of $198.98.
Previous days news about Progressive Corporation(PGR)
- According to Zacks on Friday, 12 April, "The Progressive Corporation price-consensus-eps-surprise-chart | The Progressive Corporation Quote"
4. Cogent Communications Holdings (CCOI)
14.1% sales growth and 2801.11% return on equity
Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, Europe, Asia, South America, Australia, and Africa. The company offers on-net Internet access and private network services to law firms, financial services firms, and advertising and marketing firms, as well as heath care providers, educational institutions and other professional services businesses, other Internet service providers, telephone companies, cable television companies, Web hosting companies, media service providers, mobile phone operators, content delivery network companies, and commercial content and application service providers. It also provides Internet access and private network services to customers that are not located in buildings directly connected to its network; and on-net services to customers located in buildings that are physically connected to its network. In addition, the company offers off-net services to corporate customers using other carriers' circuits to provide the last mile portion of the link from the customers' premises to the network. Further, it operates data centers that allow its customers to collocate their equipment and access the network. The company operates 54 data centers and provides facilities to 3,035 buildings and on-net services to 1,817 to multi-tenant office buildings. It serves primarily to small and medium-sized businesses, communications service providers, and other bandwidth-intensive organizations. Cogent Communications Holdings, Inc. was founded in 1999 and is headquartered in Washington, the District of Columbia.
Earnings Per Share
As for profitability, Cogent Communications Holdings has a trailing twelve months EPS of $26.62.
PE Ratio
Cogent Communications Holdings has a trailing twelve months price to earnings ratio of 2.42. Meaning, the purchaser of the share is investing $2.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2801.11%.
5. Embraer S.A. (ERJ)
13% sales growth and 5.33% return on equity
Embraer S.A. designs, develops, manufactures, and sells aircrafts and systems in Brazil, North America, Latin America, the Asia Pacific, Brazil, Europe, and internationally. It operates through Commercial Aviation; Defense and Security; Executive Jets; Service & Support; and Other segments. The Commercial Aviation segment designs, develops, and manufactures a variety of commercial aircrafts. The Defense and Security segment engages in the research, development, production, modification, and support for military defense and security aircraft; and offers a range of products and integrated solutions that include radars and special space systems, as well as information and communications systems comprising command, control, communications, computer, intelligence, surveillance, and reconnaissance systems. The Executive Jets segment develops, produces, and sells executive jets. It also leases Legacy 600 and Legacy 650 executive jets in the super midsize and large categories; Legacy 450 and Legacy 500 executive jets in the midlight and midsize categories; Phenom family executive jets in the entry jet and light jet categories; Lineage 1000, an ultra-large executive jet; and Praetor 500 and Praetor 600, disruptive executive jets in the midsize and super midsize categories. The Service & Support segment offers after-service solutions, support, and maintenance, repair, and overhaul services for commercial, executive, and defense aircrafts; provides aircraft components and engines; and supplies steel and composite aviation structures to various aircraft manufacturers. The Other segment is involved in the supply of fuel systems, structural parts, and mechanical and hydraulic systems; and production of agricultural crop-spraying aircraft. The company was formerly known as Embraer-Empresa Brasileira de Aeronáutica S.A. and changed its name to Embraer S.A. in November 2010. Embraer S.A. was incorporated in 1969 and is headquartered in São Paulo, Brazil.
Earnings Per Share
As for profitability, Embraer S.A. has a trailing twelve months EPS of $-1.25.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.33%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 64.6% and a drop 16.1% for the next.
6. Futu Holdings (FUTU)
12% sales growth and 19.95% return on equity
Futu Holdings Limited provides digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. It offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. The company also provides financial information and online community services; online wealth management services under the brand of Money Plus through its Futubull and moomoo platforms, which give access to mutual funds, private funds, and bonds; market data and information services; and NiuNiu Community, which serves as an open forum for users and clients to share insights, ask questions, and exchange ideas. In addition, the company provides initial public offering subscription and employee share option plan solution services. Futu Holdings Limited was founded in 2007 and is based in Sheung Wan, Hong Kong.
Earnings Per Share
As for profitability, Futu Holdings has a trailing twelve months EPS of $3.9.
PE Ratio
Futu Holdings has a trailing twelve months price to earnings ratio of 14.74. Meaning, the purchaser of the share is investing $14.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.95%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Futu Holdings’s EBITDA is 6.05.
Moving Average
Futu Holdings’s worth is way higher than its 50-day moving average of $50.20 and way above its 200-day moving average of $51.79.
Yearly Top and Bottom Value
Futu Holdings’s stock is valued at $57.49 at 06:22 EST, way below its 52-week high of $67.49 and way above its 52-week low of $35.91.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 2.1% and a drop 29.6% for the next.
7. Darden Restaurants (DRI)
9.1% sales growth and 49.72% return on equity
Darden Restaurants, Inc., together with its subsidiaries, owns and operates full-service restaurants in the United States and Canada. It operates under Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Yard House, The Capital Grille, Seasons 52, Bahama Breeze, Eddie V's Prime Seafood, and Capital Burger brand names. Darden Restaurants, Inc. was incorporated in 1995 and is based in Orlando, Florida.
Earnings Per Share
As for profitability, Darden Restaurants has a trailing twelve months EPS of $8.53.
PE Ratio
Darden Restaurants has a trailing twelve months price to earnings ratio of 17.94. Meaning, the purchaser of the share is investing $17.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.72%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 11.01B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 9, 2024, the estimated forward annual dividend rate is 5.14 and the estimated forward annual dividend yield is 3%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 13.2% and 1.6%, respectively.
Sales Growth
Darden Restaurants’s sales growth for the next quarter is 9.1%.
8. Artesian Resources Corporation (ARTNA)
6.9% sales growth and 7.98% return on equity
Artesian Resources Corporation, through its subsidiaries, provides water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The company distributes and sells water to residential, commercial, industrial, governmental, municipal, and utility customers, as well as for public and private fire protection in the states of Delaware, Maryland, and Pennsylvania; and offers wastewater collection, treatment infrastructure, and wastewater services to customers in Delaware. It also provides contract water and wastewater services; water, sewer, and internal service line protection plans; and wastewater management services, as well as design, construction, and engineering services. In addition, the company offers services to other water utilities, including operations and billing functions; owns real estate properties, including land for office buildings, a water treatment plant, and wastewater facility; and provides design, installation, maintenance, and repair services related to existing or proposed storm water management systems. As of December 31, 2021, it served approximately 91,700 customers in Delaware, 2,500 customers in Maryland, and 40 customers in Pennsylvania through 1,368 miles of transmission and distribution mains. Artesian Resources Corporation was founded in 1905 and is headquartered in Newark, Delaware.
Earnings Per Share
As for profitability, Artesian Resources Corporation has a trailing twelve months EPS of $1.67.
PE Ratio
Artesian Resources Corporation has a trailing twelve months price to earnings ratio of 21.53. Meaning, the purchaser of the share is investing $21.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.98%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Artesian Resources Corporation’s EBITDA is 57.83.
Yearly Top and Bottom Value
Artesian Resources Corporation’s stock is valued at $35.95 at 06:22 EST, way below its 52-week high of $58.41 and higher than its 52-week low of $33.84.
Volume
Today’s last reported volume for Artesian Resources Corporation is 41336 which is 11.98% above its average volume of 36911.
